Revance Therapeutics (NQ: RVNC )
6.570
-0.010
(-0.15%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
All News about Revance Therapeutics
Via Business Wire
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID
November 17, 2022
Exposures
COVID-19
Revance to Participate in the Stifel 2022 Healthcare Conference
November 09, 2022
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Via Benzinga
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2022
September 22, 2022
Via Benzinga
Revance to Participate in the Guggenheim Nantucket Therapeutics Conference
September 21, 2022
Via Business Wire
Via Business Wire
Revance Announces Proposed Public Offering of Common Stock
September 12, 2022
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.